The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

19 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of Antimalarial Azetidine-2-carbonitriles That InhibitEBI
Harvard University
Discovery of 8-Membered Ring Sulfonamides as Inhibitors of Oncogenic Mutant Isocitrate Dehydrogenase 1.EBI
Harvard University
OpenGrowth: An Automated and Rational Algorithm for Finding New Protein Ligands.EBI
Harvard University
Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 2. Applications.EBI
Harvard University
Genetic neural networks for quantitative structure-activity relationships: improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors.EBI
Harvard University
Structure of human cytidine deaminase bound to a potent inhibitor.EBI
Harvard University
2,6-Dimethyltyrosine analogues of a stereodiversified ligand library: highly potent, selective, non-peptidic mu opioid receptor agonists.EBI
Harvard University
Multiple copy simultaneous search and construction of ligands in binding sites: application to inhibitors of HIV-1 aspartic proteinase.EBI
Harvard University
Microarray-based method for monitoring yeast overexpression strains reveals small-molecule targets in TOR pathway.EBI
Harvard University
Molecular basis of cyclin-CDK-CKI regulation by reversible binding of an inositol pyrophosphate.EBI
Harvard University
Design and Development of IKZF2 and CK1α Dual Degraders.EBI
Harvard University
Development of a highly potent and selective degrader of LRRK2.EBI
Harvard University
Potent Uncompetitive Inhibitors of Nicotinamide EBI
Harvard University
Discovery of a Cyclic Choline Analog That Inhibits Anaerobic Choline Metabolism by Human Gut Bacteria.EBI
Harvard University
Identification of two hydrophobic patches in the active-site cavity of human carbonic anhydrase II by solution-phase and solid-state studies and their use in the development of tight-binding inhibitors.EBI
Harvard University
SMall Molecule Growth 2001 (SMoG2001): an improved knowledge-based scoring function for protein-ligand interactions.EBI
Harvard University
Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitorsBDB
Allergan
A new screening assay for allosteric inhibitors of cSrc.BDB
Chemical Genomics Centre of The Max Planck Society